Development of the Lung

Introduction

Embryological Origin

• The lung originates from the laryngotracheal groove of the endoderm, located at the fourth pharyngeal arch.
• The splanchnic mesoderm provides muscular and cartilaginous covering to the lung and forms the visceral pleura.
• The somatic mesoderm forms the parietal pleura.
• The laryngotracheal groove outpouches from the foregut, forming the respiratory diverticulum (tracheal bud), which separates from the esophagus.
• The tracheal bud branches into two primary bronchi (left and right), then into secondary (lobar) bronchi: three on the right (for 3 lobes) and two on the left (for 2 lobes) by 5 weeks of gestation.

Five Stages of Lung Development

1. Embryonic Stage (4–5 weeks)

• Laryngotracheal groove outpouches to form the respiratory diverticulum.
• Tracheal bud separates from the esophagus.
• Primary bronchi form; secondary (lobar) bronchi develop by 5 weeks.

2. Pseudoglandular Stage (5–16 weeks)

• The lung grows laterally and caudally on exposure to splanchnic mesoderm.
• Conducting airways branch progressively until terminal bronchioles (16th to 25th generation) are formed by 16 weeks.
• The mesenchymal tissue begins to differentiate into:
  • Ciliated columnar epithelial cells
  • Goblet cells
  • Type II pneumocytes (precursors)
• This stage marks the transition between conducting and respiratory airways.
• Alveolar myofibroblasts surround distal lung epithelial tubules and buds during this stage; they are essential for later secondary septation.

3. Canalicular Stage (16–26 weeks)

• The epithelium differentiates into type I pneumocytes (alveolar cells) - the primary structural cells responsible for gas exchange.
• Extensive angiogenesis occurs, forming the capillary network surrounding alveolar cells.
• Lamellar bodies (inclusion bodies) form within type II pneumocytes - the primary sites for surfactant storage.
• Conducting airways continue to elongate and widen, giving a canalicular appearance.
• A fetus born at this stage may survive with intensive respiratory support, as minimal gas exchange surface is present.

4. Saccular Stage (26 weeks to term)

• Progressive maturation of type I and type II pneumocytes.
• Decrease in interstitial tissue leads to the formation of air spaces (primary sacculi) - the location of future gas exchange.
• Exponential growth in primary sacculi with formation of the primary septum between each saccular unit.
• Primary septa contain a double-layered capillary network.
• Mesenchymal tissue differentiates into:
  • Smooth muscle cells
  • A fibroelastic network of collagen fibrils - the foundation for alveolarization.

5. Alveolar (Alveolarization) Stage (Postnatal)

• Secondary septation begins: secondary septa arise from primary septa, subdividing the primary sacculi into alveoli.
• The double capillary loops fuse into a single capillary loop in the definitive alveolar wall.
• Alveolar myofibroblasts play a key role - their absence results in deficient secondary septation and failure of alveolar development.
• The alveolar surface area increases dramatically postnatally.
• Alveolarization continues until approximately 8 years of age in humans.

Role of Fetal Lung Fluid

• Fetal lung fluid is secreted by the lung epithelium and plays a mechanical role in maintaining lung expansion.
• Adequate fetal lung fluid volume is critical for normal lung growth.
• Oligohydramnios (reduced amniotic fluid, e.g., from renal agenesis) causes pulmonary hypoplasia due to reduced mechanical stretch stimulus on the developing lung.

Molecular Mechanisms

• Lung morphogenesis depends on reciprocal signaling between mesenchyme and epithelium.
• Key molecular regulators include:
  • FGF (Fibroblast Growth Factor) signaling - branching morphogenesis
  • Wnt signaling - epithelial-mesenchymal crosstalk
  • Shh (Sonic Hedgehog) - separation of trachea from esophagus and airway patterning
  • TGF-beta - mesenchymal differentiation and myofibroblast activation
• Disruption of these pathways leads to congenital anomalies such as tracheo-esophageal fistula, bronchial atresia, and CPAM.

Classification of Developmental Disorders

• Airway disorders: Tracheal agenesis, bronchial atresia, congenital tracheobronchomegaly (Mounier-Kuhn), bronchogenic cyst, CPAM, bronchopulmonary sequestration
• Parenchymal disorders: Congenital lobar emphysema, pulmonary hypoplasia, pulmonary cystic mesenchymal hamartoma
• Vascular disorders: Pulmonary artery sling, unilateral absent pulmonary artery, Scimitar syndrome

Clinical Relevance

• Prenatal ultrasonography and Doppler are first-line screening tools.
• Some anomalies resolve spontaneously before birth; others persist with a spectrum of severity.
• Asymptomatic anomalies often discovered incidentally in adults may be misidentified as malignant or infectious lesions on chest imaging.
• A clinico-radiologic approach is needed for accurate identification and management.

Development of the Lung

Introduction

Embryological Origin

• The lung arises from the laryngotracheal groove of the endoderm at the fourth pharyngeal arch (Fishman).
• Epithelial cells arise from the endoderm; mesenchymal and endothelial cells arise from the mesoderm (Murray).
• The splanchnic mesoderm provides muscular and cartilaginous covering and forms the visceral pleura.
• The somatic mesoderm forms the parietal pleura.
• The laryngotracheal groove outpouches from the foregut as the respiratory diverticulum (tracheal bud), which separates from the esophagus.
• The tracheal bud divides into two primary bronchi, then secondary (lobar) bronchi (3 right, 2 left) by 5 weeks of gestation.

Five Stages of Lung Development

Stage 1: Embryonic Stage (4–5 weeks gestation)

• The laryngotracheal groove outpouches from the foregut to form the respiratory diverticulum.
• Tracheal bud elongates and separates from the esophagus - disruption of Sonic Hedgehog (Shh) signaling at this step leads to tracheo-esophageal fistula.
• The bud branches into left and right primary bronchi, then into secondary (lobar) bronchi by 5 weeks.
• The primary lung field is specified by NKX2.1 (TTF-1) transcription factor - the master regulator of lung identity (Murray).

Stage 2: Pseudoglandular Stage (5–16 weeks)

• The lung grows laterally and caudally under the influence of the splanchnic mesoderm.
• Conducting airways branch progressively until terminal bronchioles (16th to 25th generation) are formed by 16 weeks.
• The lung at this stage histologically resembles a gland - hence "pseudoglandular."
• Mesenchymal tissue differentiates into:
  • Ciliated columnar epithelial cells
  • Goblet cells (secretory)
  • Club cells (formerly Clara cells)
  • Precursors of type II pneumocytes
• Submucosal glands are prevalent in the human conducting airways and are lined by serous and goblet cells, with myoepithelial cells in the basal layer (Murray).
• Alveolar myofibroblasts surround distal epithelial tubules and buds during this stage; they are essential for later secondary septation. Their absence causes deficient alveolar development (Fishman).
• Key signaling: FGF10-FGFR2 axis drives branching morphogenesis; Wnt signaling regulates epithelial-mesenchymal crosstalk.

Stage 3: Canalicular Stage (16–26 weeks)

• Epithelium differentiates into type I pneumocytes (AT1 cells) - the primary structural cells for gas exchange, covering ~95% of alveolar surface area.
• Type II pneumocytes (AT2 cells) develop and form lamellar bodies - organelles that store and secrete pulmonary surfactant (Murray).
• Extensive angiogenesis produces the capillary network surrounding alveolar cells - driven by VEGF signaling.
• Conducting airways elongate and widen, giving the canalicular appearance on histology.
• Airway epithelial cells begin to differentiate at midgestation, while alveolar epithelial cells differentiate near the end of gestation - in time to support gas exchange at birth (Murray).
• A fetus born at 24–25 weeks may survive with respiratory support as minimal gas exchange surface exists.

Stage 4: Saccular Stage (26 weeks to term)

• Progressive maturation of type I and type II pneumocytes with decreasing interstitial tissue.
• Primary sacculi form - the precursors of future alveoli; these are the sites of gas exchange.
• Exponential growth in primary sacculi with primary septa forming between each unit.
• Primary septa at this stage contain a double-layered capillary network (characteristic feature).
• Mesenchymal tissue further differentiates into:
  • Smooth muscle cells
  • Fibroelastic network of collagen fibrils - the structural foundation for alveolarization.
• Surfactant production increases, becoming sufficient for postnatal respiration around 35 weeks (clinical relevance for RDS in prematurity).

Stage 5: Alveolar Stage (Postnatal)

• Secondary septation: secondary septa arise from primary septa, subdividing primary sacculi into true alveoli.
• The double capillary loops of the primary septa fuse into a single capillary loop in the mature alveolar wall - increasing gas exchange efficiency.
• AT2 cells serve as progenitors and can give rise to AT1 cells that cover the alveolar surface (Murray).
• Alveolar myofibroblasts (present during alveologenesis) are absent in the adult lung - their clearance after septation is an active process (Fishman).
• Murray notes: the conventional view suggests alveolar formation is complete by 6–7 years of age, but recent studies show new alveoli continue to be added into the 20s in humans.
• 95% of the total alveolar surface area is added after birth (Murray).

Cell Types of the Mature Lung (Murray)

• Goblet cells and Club cells - secretory
• Ciliated cells - mucociliary clearance
• Basal cells - progenitors that replace damaged luminal cells after injury
• Rare cells: pulmonary neuroendocrine cells, ionocytes, tuft cells

• AT2 cells - produce surfactant; serve as progenitors for AT1 cells
• AT1 cells - cover 95% of alveolar surface; primary gas exchange interface

• Myofibroblasts, matrix fibroblasts, lipofibroblasts, pericytes (distinguished by single-cell RNA sequencing)

Molecular Regulation of Lung Development

Role of Fetal Lung Fluid

• Fetal lung fluid is secreted by the lung epithelium and fills the nascent airways.
• It exerts mechanical stretch on the developing epithelium, which is a key stimulus for normal lung growth.
• Oligohydramnios (e.g., from renal agenesis - Potter sequence) reduces amniotic fluid, limits fetal breathing movements, and causes pulmonary hypoplasia due to the loss of mechanical distension.

Pulmonary Vasculature Development (Murray)

• Pulmonary endothelial cells give rise to three distinct vascular networks:
  1. Pulmonary arteries (carrying deoxygenated blood to lungs)
  2. Pulmonary veins (carrying oxygenated blood from lungs)
  3. Bronchial circulation (systemic supply to airway walls)
• The pulmonary circulation is unique - opposite to all other tissues in the body in carrying deoxygenated blood to, and oxygenated blood from, the organ.

Developmental Disorders

Clinical Significance

• Preterm birth and BPD (Bronchopulmonary Dysplasia): disruption of the saccular/alveolar stages leads to arrested alveolar development, poor gas exchange in infancy persisting into adulthood.
• Surfactant deficiency: prematurity interrupts canalicular/saccular maturation - basis of Respiratory Distress Syndrome (RDS) in neonates.
• Reduced early lung capacity - from any cause - leads to premature decline of respiratory function during aging and increased susceptibility to COPD (Murray).
• Many congenital anomalies remain subclinical and are discovered incidentally in adulthood, where they are often misidentified as malignant or infectious lesions on chest imaging.

Emerging Technologies (Murray)

• iPSC-derived lung cells: patient-derived induced pluripotent stem cells differentiated into lung lineages for disease modeling and therapy.
• Lung Organoids: 3D miniature lung structures recapitulating key developmental steps.
• CRISPR/Cas9: disease mutation correction in iPSCs and in vivo editing of lung cells; in utero lung editing achieved in animal models - promising for cystic fibrosis.
• Single-cell RNA sequencing (scRNA-seq): revealed heterogeneity within morphologically similar cell types (e.g., AT2 subpopulations, multiple mesenchymal subtypes); identified rare ionocytes and tuft cells.

• Fishman's Pulmonary Diseases and Disorders, 5th Ed., Chapter 105 - Deshwal & Ghosh
• Murray & Nadel's Textbook of Respiratory Medicine, Chapter 2 - Stages of Lung Development with Cellular and Molecular Mechanisms